Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/31746
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sathianathen, Niranjan J | - |
dc.contributor.author | Pan, Henry Y C | - |
dc.contributor.author | Lawrentschuk, Nathan | - |
dc.contributor.author | Siva, Shankar | - |
dc.contributor.author | Azad, Arun A | - |
dc.contributor.author | Tran, Ben | - |
dc.contributor.author | Bolton, Damien M | - |
dc.contributor.author | Murphy, Declan G | - |
dc.date | 2022 | - |
dc.date.accessioned | 2023-01-12T02:52:49Z | - |
dc.date.available | 2023-01-12T02:52:49Z | - |
dc.date.issued | 2023-05 | - |
dc.identifier.citation | Urologic Oncology 2023-05; 41(5) | en_US |
dc.identifier.issn | 1873-2496 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/31746 | - |
dc.description.abstract | There have been a growing number of treatment options available for men with metastatic castration-sensitive prostate cancer. Not only have newer agents entered the clinical landscape, there is a trend toward treatment intensification by combining multiple agents simultaneously. We aim to assess the best contemporary treatment option for men with mCSPC. | en_US |
dc.language.iso | eng | - |
dc.subject | Chemotherapy | en_US |
dc.subject | Meta analysis | en_US |
dc.subject | Metastatic disease | en_US |
dc.subject | Prostate cancer | en_US |
dc.subject | Systematic review | en_US |
dc.title | Emergence of triplet therapy for metastatic castration-sensitive prostate cancer: An updated systematic review and network meta-analysis. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Urologic Oncology | en_US |
dc.identifier.affiliation | Division of Cancer Surgery, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia | en_US |
dc.identifier.affiliation | Department of Urology, Royal Melbourne Hospital, Parkville, Victoria, Australia. | en_US |
dc.identifier.affiliation | Division of Radiation Oncology, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia | en_US |
dc.identifier.affiliation | Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. | en_US |
dc.identifier.affiliation | Surgery (University of Melbourne) | en_US |
dc.identifier.doi | 10.1016/j.urolonc.2022.10.016 | en_US |
dc.type.content | Text | en_US |
dc.identifier.pubmedid | 36411180 | - |
local.name.researcher | Bolton, Damien M | |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Urology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.